| Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma JM Herman, DT Chang, KA Goodman, AS Dholakia, SP Raman, ... Cancer 121 (7), 1128-1137, 2015 | 441 | 2015 |
| Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas DT Chang, D Schellenberg, J Shen, J Kim, KA Goodman, GA Fisher, ... Cancer 115 (3), 665-672, 2009 | 413 | 2009 |
| Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis DT Chang, A Swaminath, M Kozak, J Weintraub, AC Koong, J Kim, ... Cancer 117 (17), 4060-4069, 2011 | 332 | 2011 |
| Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology AB Benson, MI D’Angelica, DE Abbott, DA Anaya, R Anders, C Are, ... Journal of the National Comprehensive Cancer Network 19 (5), 541-565, 2021 | 331 | 2021 |
| NCCN guidelines insights: hepatobiliary cancers, version 1.2017 AB Benson, MI D'Angelica, DE Abbott, TA Abrams, SR Alberts, DA Anaya, ... Journal of the National Comprehensive Cancer Network 15 (5), 563-573, 2017 | 297 | 2017 |
| Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid … DT Chang, RK Pai, LA Rybicki, MA Dimaio, M Limaye, P Jayachandran, ... Modern Pathology 25 (8), 1128-1139, 2012 | 272 | 2012 |
| A systemic complete response of metastatic melanoma to local radiation and immunotherapy SM Hiniker, DS Chen, S Reddy, DT Chang, JC Jones, JA Mollick, ... Translational oncology 5 (6), 404-407, 2012 | 245 | 2012 |
| Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer D Schellenberg, J Kim, C Christman-Skieller, CL Chun, LA Columbo, ... International Journal of Radiation Oncology* Biology* Physics 81 (1), 181-188, 2011 | 241 | 2011 |
| NCCN guidelines insights: Hepatobiliary cancers, version 2.2019: Featured updates to the NCCN guidelines AB Benson, MI D’Angelica, DE Abbott, TA Abrams, SR Alberts, DA Anaya, ... Journal of the National Comprehensive Cancer Network 17 (4), 302-310, 2019 | 220 | 2019 |
| Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy N Kothary, JJ Heit, JD Louie, WT Kuo, BW Loo Jr, A Koong, DT Chang, ... Journal of vascular and interventional radiology 20 (2), 235-239, 2009 | 210 | 2009 |
| BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic … RK Pai, P Jayachandran, AC Koong, DT Chang, S Kwok, L Ma, DA Arber, ... The American journal of surgical pathology 36 (5), 744, 2012 | 192 | 2012 |
| HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment PL Kunz, A Mojtahed, GA Fisher, JM Ford, DT Chang, RR Balise, ... Applied immunohistochemistry & molecular morphology: AIMM 20 (1), 13, 2012 | 172 | 2012 |
| A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer JD Murphy, C Christman-Skieller, J Kim, S Dieterich, DT Chang, ... International Journal of Radiation Oncology* Biology* Physics 78 (5), 1420-1426, 2010 | 171 | 2010 |
| Do pre‐irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? DT Chang, PR Sandow, CG Morris, R Hollander, L Scarborough, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2007 | 166 | 2007 |
| Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer MB Yurgelun, AB Chittenden, V Morales-Oyarvide, DA Rubinson, ... Genetics in Medicine 21 (1), 213-223, 2019 | 165 | 2019 |
| Intensity‐modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal JG Bazan, W Hara, A Hsu, PA Kunz, J Ford, GA Fisher, ML Welton, ... Cancer 117 (15), 3342-3351, 2011 | 156 | 2011 |
| Intensity‐modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal JG Bazan, W Hara, A Hsu, PA Kunz, J Ford, GA Fisher, ML Welton, ... Cancer 117 (15), 3342-3351, 2011 | 156 | 2011 |
| EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy WG Park, BM Yan, D Schellenberg, J Kim, DT Chang, A Koong, ... Gastrointestinal endoscopy 71 (3), 513-518, 2010 | 154 | 2010 |
| A p53 super-tumor suppressor reveals a tumor suppressive p53-Ptpn14-Yap axis in pancreatic cancer SS Mello, LJ Valente, N Raj, JA Seoane, BM Flowers, J McClendon, ... Cancer cell 32 (4), 460-473. e6, 2017 | 139 | 2017 |
| Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma ZR Qian, DA Rubinson, JA Nowak, V Morales-Oyarvide, RF Dunne, ... JAMA oncology 4 (3), e173420-e173420, 2018 | 132 | 2018 |
